How will the pandemic shape biotech in the months ahead?

How will the pandemic shape biotech in the months ahead?

STAT Plus: How will the pandemic shape biotech in the months ahead? An industry analyst weighs in

By ADAM FEUERSTEIN AND DAMIAN GARDE AND REBECCA ROBBINS

ADOBE

Industry analyst Brian Skorney weighs in on clinical trial delays, experimental Covid-19 treatments, and Biogen's long-awaited aducanumab application.

READ MORE